Ph.D. J. Vajda M.D.

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Sorry, we do not have enough data to show an influence graph for this author.
Learn More
According to our recent observation the patients can be divided into two groups of therapy. In group I. the patients with elevated TCD values and either low or high ICP reacting to LLD. We consider that haemodilution and moderate hypervolaemia should dominate in the triple H therapy. In group II patients having high ICP with TCD and/or symptomatic vasospasm(More)
  • 1